EPHB4 and neoplasm: Subsequently, the PDGF-BB ligand promotes the direct activation of PDGFRβ and indirect activation of EPHB4, which eventually stimulates Akt and Erk1/2 signaling pathways that enhance tumor cell survival and proliferation, respectively [29].